GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BB Biotech AG (GREY:BBAGF) » Definitions » Cyclically Adjusted PB Ratio

BB Biotech AG (BB Biotech AG) Cyclically Adjusted PB Ratio : 1.13 (As of May. 14, 2024)


View and export this data going back to . Start your Free Trial

What is BB Biotech AG Cyclically Adjusted PB Ratio?

As of today (2024-05-14), BB Biotech AG's current share price is $76.05789. BB Biotech AG's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2023 was $67.05. BB Biotech AG's Cyclically Adjusted PB Ratio for today is 1.13.

The historical rank and industry rank for BB Biotech AG's Cyclically Adjusted PB Ratio or its related term are showing as below:

BBAGF' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 0.96   Med: 1.15   Max: 1.27
Current: 1.13

During the past years, BB Biotech AG's highest Cyclically Adjusted PB Ratio was 1.27. The lowest was 0.96. And the median was 1.15.

BBAGF's Cyclically Adjusted PB Ratio is ranked better than
62.48% of 645 companies
in the Biotechnology industry
Industry Median: 1.79 vs BBAGF: 1.13

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

BB Biotech AG's adjusted book value per share data for the three months ended in Dec. 2023 was $48.981. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $67.05 for the trailing ten years ended in Dec. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


BB Biotech AG Cyclically Adjusted PB Ratio Historical Data

The historical data trend for BB Biotech AG's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BB Biotech AG Cyclically Adjusted PB Ratio Chart

BB Biotech AG Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.06 - 0.98 1.21 1.13

BB Biotech AG Quarterly Data
Jun16 Sep16 Dec16 Mar17 Jun17 Dec17 Dec18 Dec19 Dec20 Mar21 Jun21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.21 1.18 1.16 1.15 1.13

Competitive Comparison of BB Biotech AG's Cyclically Adjusted PB Ratio

For the Biotechnology subindustry, BB Biotech AG's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BB Biotech AG's Cyclically Adjusted PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, BB Biotech AG's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where BB Biotech AG's Cyclically Adjusted PB Ratio falls into.



BB Biotech AG Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

BB Biotech AG's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=76.05789/67.05
=1.13

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BB Biotech AG's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2023 is calculated as:

For example, BB Biotech AG's adjusted Book Value per Share data for the three months ended in Dec. 2023 was:

Adj_Book=Book Value per Share/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=48.981/106.4611*106.4611
=48.981

Current CPI (Dec. 2023) = 106.4611.

BB Biotech AG Quarterly Data

Book Value per Share CPI Adj_Book
201106 14.218 102.678 14.742
201109 11.593 101.811 12.123
201112 16.303 101.408 17.115
201203 16.564 101.826 17.318
201206 17.549 101.596 18.389
201209 129.480 101.392 135.954
201212 117.920 100.968 124.335
201303 125.071 101.221 131.545
201306 151.958 101.466 159.438
201309 30.994 101.336 32.562
201312 34.761 101.036 36.628
201403 34.969 101.224 36.778
201406 37.581 101.517 39.411
201409 43.553 101.247 45.796
201412 63.477 100.704 67.106
201503 67.180 100.339 71.279
201506 77.218 100.464 81.828
201509 64.013 99.785 68.296
201512 71.780 99.386 76.890
201603 47.804 99.475 51.161
201606 49.046 100.088 52.169
201609 56.174 99.604 60.041
201612 53.190 99.380 56.980
201703 58.164 100.040 61.897
201706 62.071 100.285 65.894
201712 64.716 100.213 68.751
201812 52.492 100.906 55.382
201912 62.330 101.063 65.659
202012 78.987 100.241 83.889
202103 0.000 100.800 0.000
202106 0.000 101.352 0.000
202112 64.478 101.776 67.446
202203 53.886 103.205 55.586
202206 47.229 104.783 47.985
202209 0.000 104.835 0.000
202212 52.572 104.666 53.474
202303 44.838 106.245 44.929
202306 45.815 106.576 45.766
202309 44.875 106.570 44.829
202312 48.981 106.461 48.981

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


BB Biotech AG  (GREY:BBAGF) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


BB Biotech AG Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of BB Biotech AG's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


BB Biotech AG (BB Biotech AG) Business Description

Industry
Traded in Other Exchanges
Address
Schwertstrasse 6, Schaffhausen, CHE, CH-8200
BB Biotech AG is a part of the healthcare sector in Switzerland. Its primary activity includes making investments, especially in the biotechnology market and is one of the largest investors in the field of biotechnology. The focus of the investments is on those listed companies that focus on the development and marketing of novel drugs with a clear value for the healthcare system. BB Biotech follows a strategy of carefully screening and selecting biotechnology firms with a long-term time horizon and having established products in the marketplace. Geographically it earns key revenue from the Netherlands.

BB Biotech AG (BB Biotech AG) Headlines

No Headlines